Clinical Trial Update: Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD [Phase 3]

View source ↗

Summary

A phase 3 clinical trial evaluating the efficacy and safety of Leukotac (Inolimomab) in pediatric patients with steroid-refractory graft-versus-host disease (SR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-refractory Graft-versus-host Disease in Children

Drugs mentioned

• Leukotac (Inolimomab) (Inolimomab)

Snippet

Sponsor: ElsaLys Biotech | Conditions: Steroid Refractory GVHD | Phase 3 | Status: UNKNOWN